BiDil FDA Approval History
FDA Approved: Yes (First approved June 23, 2005)
Brand name: BiDil
Generic name: isosorbide dinitrate and hydralazine
Dosage form: Tablets
Company: NitroMed, Inc.
Treatment for: Heart Failure
BiDil is a fixed-dose combination of isosorbide dinitrate (a vasodilator) and hydralazine hydrochloride (an arterial dilator) indicated for the treatment of heart failure in black patients.
Development timeline for BiDil
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.